Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes

Role of endothelin-1

Mostafa M. Elgebaly, Aisha Kelly, Alex K. Harris, Hazem Elewa, Vera Portik-Dobos, Pimonrat Ketsawatsomkron, Mario B Marrero, Adviye Ergul

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Insulin resistance involves decreased phosphorylation of insulin receptor substrate (IRS) proteins and (or) Akt. In the vasculature, modulated Akt phosphorylation may cause impaired vasorelaxation via decreased eNOS activation. Diet-induced insulin resistance enhances endothelin-1(ET-1)-mediated vasoconstriction and prevents vasodilatation to insulin. Presently, we evaluated insulin-mediated vascular relaxation, assessed molecular markers of the insulin signaling pathway, and determined the involvement of ET-1 in response to insulin by using selective ETA- or ETB-receptor blockade in a lean model of type 2 diabetes. Dose-response curves to insulin (0.01-100 ng/mL) were generated with wire myograph using thoracic aorta rings from control Wistar or diabetic Goto-Kakizaki (GK) rats (n = 3-11). Maximal relaxation (Rmax) to insulin was significantly impaired and insulin sensitivity was decreased in the GK group. Preincubation with 1 μmol/L BQ-123 or BQ-788 for ETA- and ETB-receptor blockade, respectively, resulted in improved insulin sensitivity. Immunoblotting for native and phosphorylated Akt and IRS-1 revealed a decrease in Akt activation in the GK group. In vivo hyperinsulinemic euglycemic clamp studies showed decreased glucose utilization in GK rats, indicative of insuhn resistance. These findings provide evidence that vascular insulin resistance occurs in a nonobese model of diabetes and that both ET receptor subtypes are involved in vascular relaxation to insulin.

Original languageEnglish (US)
Pages (from-to)358-364
Number of pages7
JournalCanadian Journal of Physiology and Pharmacology
Volume86
Issue number6
DOIs
StatePublished - Jun 1 2008

Fingerprint

Endothelin-1
Vasodilation
Type 2 Diabetes Mellitus
Insulin
Insulin Resistance
Insulin Receptor Substrate Proteins
Blood Vessels
Phosphorylation
Glucose Clamp Technique
Vasoconstriction
Thoracic Aorta
Immunoblotting
Vascular Resistance
Diet
Glucose

Keywords

  • Endothelin-1
  • Type II diabetes
  • Vascular insulin resistance

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Elgebaly, M. M., Kelly, A., Harris, A. K., Elewa, H., Portik-Dobos, V., Ketsawatsomkron, P., ... Ergul, A. (2008). Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: Role of endothelin-1. Canadian Journal of Physiology and Pharmacology, 86(6), 358-364. https://doi.org/10.1139/Y08-034

Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes : Role of endothelin-1. / Elgebaly, Mostafa M.; Kelly, Aisha; Harris, Alex K.; Elewa, Hazem; Portik-Dobos, Vera; Ketsawatsomkron, Pimonrat; Marrero, Mario B; Ergul, Adviye.

In: Canadian Journal of Physiology and Pharmacology, Vol. 86, No. 6, 01.06.2008, p. 358-364.

Research output: Contribution to journalArticle

Elgebaly, MM, Kelly, A, Harris, AK, Elewa, H, Portik-Dobos, V, Ketsawatsomkron, P, Marrero, MB & Ergul, A 2008, 'Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: Role of endothelin-1', Canadian Journal of Physiology and Pharmacology, vol. 86, no. 6, pp. 358-364. https://doi.org/10.1139/Y08-034
Elgebaly, Mostafa M. ; Kelly, Aisha ; Harris, Alex K. ; Elewa, Hazem ; Portik-Dobos, Vera ; Ketsawatsomkron, Pimonrat ; Marrero, Mario B ; Ergul, Adviye. / Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes : Role of endothelin-1. In: Canadian Journal of Physiology and Pharmacology. 2008 ; Vol. 86, No. 6. pp. 358-364.
@article{6807d7ec1675469a97951abd7ee87d65,
title = "Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: Role of endothelin-1",
abstract = "Insulin resistance involves decreased phosphorylation of insulin receptor substrate (IRS) proteins and (or) Akt. In the vasculature, modulated Akt phosphorylation may cause impaired vasorelaxation via decreased eNOS activation. Diet-induced insulin resistance enhances endothelin-1(ET-1)-mediated vasoconstriction and prevents vasodilatation to insulin. Presently, we evaluated insulin-mediated vascular relaxation, assessed molecular markers of the insulin signaling pathway, and determined the involvement of ET-1 in response to insulin by using selective ETA- or ETB-receptor blockade in a lean model of type 2 diabetes. Dose-response curves to insulin (0.01-100 ng/mL) were generated with wire myograph using thoracic aorta rings from control Wistar or diabetic Goto-Kakizaki (GK) rats (n = 3-11). Maximal relaxation (Rmax) to insulin was significantly impaired and insulin sensitivity was decreased in the GK group. Preincubation with 1 μmol/L BQ-123 or BQ-788 for ETA- and ETB-receptor blockade, respectively, resulted in improved insulin sensitivity. Immunoblotting for native and phosphorylated Akt and IRS-1 revealed a decrease in Akt activation in the GK group. In vivo hyperinsulinemic euglycemic clamp studies showed decreased glucose utilization in GK rats, indicative of insuhn resistance. These findings provide evidence that vascular insulin resistance occurs in a nonobese model of diabetes and that both ET receptor subtypes are involved in vascular relaxation to insulin.",
keywords = "Endothelin-1, Type II diabetes, Vascular insulin resistance",
author = "Elgebaly, {Mostafa M.} and Aisha Kelly and Harris, {Alex K.} and Hazem Elewa and Vera Portik-Dobos and Pimonrat Ketsawatsomkron and Marrero, {Mario B} and Adviye Ergul",
year = "2008",
month = "6",
day = "1",
doi = "10.1139/Y08-034",
language = "English (US)",
volume = "86",
pages = "358--364",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "6",

}

TY - JOUR

T1 - Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes

T2 - Role of endothelin-1

AU - Elgebaly, Mostafa M.

AU - Kelly, Aisha

AU - Harris, Alex K.

AU - Elewa, Hazem

AU - Portik-Dobos, Vera

AU - Ketsawatsomkron, Pimonrat

AU - Marrero, Mario B

AU - Ergul, Adviye

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Insulin resistance involves decreased phosphorylation of insulin receptor substrate (IRS) proteins and (or) Akt. In the vasculature, modulated Akt phosphorylation may cause impaired vasorelaxation via decreased eNOS activation. Diet-induced insulin resistance enhances endothelin-1(ET-1)-mediated vasoconstriction and prevents vasodilatation to insulin. Presently, we evaluated insulin-mediated vascular relaxation, assessed molecular markers of the insulin signaling pathway, and determined the involvement of ET-1 in response to insulin by using selective ETA- or ETB-receptor blockade in a lean model of type 2 diabetes. Dose-response curves to insulin (0.01-100 ng/mL) were generated with wire myograph using thoracic aorta rings from control Wistar or diabetic Goto-Kakizaki (GK) rats (n = 3-11). Maximal relaxation (Rmax) to insulin was significantly impaired and insulin sensitivity was decreased in the GK group. Preincubation with 1 μmol/L BQ-123 or BQ-788 for ETA- and ETB-receptor blockade, respectively, resulted in improved insulin sensitivity. Immunoblotting for native and phosphorylated Akt and IRS-1 revealed a decrease in Akt activation in the GK group. In vivo hyperinsulinemic euglycemic clamp studies showed decreased glucose utilization in GK rats, indicative of insuhn resistance. These findings provide evidence that vascular insulin resistance occurs in a nonobese model of diabetes and that both ET receptor subtypes are involved in vascular relaxation to insulin.

AB - Insulin resistance involves decreased phosphorylation of insulin receptor substrate (IRS) proteins and (or) Akt. In the vasculature, modulated Akt phosphorylation may cause impaired vasorelaxation via decreased eNOS activation. Diet-induced insulin resistance enhances endothelin-1(ET-1)-mediated vasoconstriction and prevents vasodilatation to insulin. Presently, we evaluated insulin-mediated vascular relaxation, assessed molecular markers of the insulin signaling pathway, and determined the involvement of ET-1 in response to insulin by using selective ETA- or ETB-receptor blockade in a lean model of type 2 diabetes. Dose-response curves to insulin (0.01-100 ng/mL) were generated with wire myograph using thoracic aorta rings from control Wistar or diabetic Goto-Kakizaki (GK) rats (n = 3-11). Maximal relaxation (Rmax) to insulin was significantly impaired and insulin sensitivity was decreased in the GK group. Preincubation with 1 μmol/L BQ-123 or BQ-788 for ETA- and ETB-receptor blockade, respectively, resulted in improved insulin sensitivity. Immunoblotting for native and phosphorylated Akt and IRS-1 revealed a decrease in Akt activation in the GK group. In vivo hyperinsulinemic euglycemic clamp studies showed decreased glucose utilization in GK rats, indicative of insuhn resistance. These findings provide evidence that vascular insulin resistance occurs in a nonobese model of diabetes and that both ET receptor subtypes are involved in vascular relaxation to insulin.

KW - Endothelin-1

KW - Type II diabetes

KW - Vascular insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=44949239600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949239600&partnerID=8YFLogxK

U2 - 10.1139/Y08-034

DO - 10.1139/Y08-034

M3 - Article

VL - 86

SP - 358

EP - 364

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 6

ER -